Behavioral economic analysis of legal and illegal cannabis demand in Spanish young adults with hazardous and non-hazardous cannabis use.
Autor: | González-Roz A; Addictive Behaviors Research Group (GCA), Department of Psychology, University of Oviedo, Oviedo 33003, Spain. Electronic address: gonzalezralba@uniovi.es., Belisario K; Peter Boris Centre for Addictions Research, St Joseph's Healthcare Hamilton and McMaster University, Hamilton, Ontario L9C 0E3, Canada., Secades-Villa R; Addictive Behaviors Research Group (GCA), Department of Psychology, University of Oviedo, Oviedo 33003, Spain., Muñiz J; Faculty of Psychology, University of Nebrija, Madrid 28015, Spain., MacKillop J; Peter Boris Centre for Addictions Research, St Joseph's Healthcare Hamilton and McMaster University, Hamilton, Ontario L9C 0E3, Canada. |
---|---|
Jazyk: | angličtina |
Zdroj: | Addictive behaviors [Addict Behav] 2024 Feb; Vol. 149, pp. 107878. Date of Electronic Publication: 2023 Oct 04. |
DOI: | 10.1016/j.addbeh.2023.107878 |
Abstrakt: | Background: In October 2021, a legal framework that regulates cannabis for recreational purposes in Spain was proposed, but research on its potential impacts on cannabis use is currently limited. This study examined the reliability and discriminant validity of two Marijuana Purchase Tasks (MPTs) for measuring hypothetical legal and illegal cannabis demand, and to examine differences in demand of both commodities in young adults at hazardous vs. non-hazardous cannabis use risk levels. Methods: A total of 171 Spanish young adults [M Results: The MPT was reliable for measuring legal (α = 0.94) and illegal (α = 0.90) cannabis demand. Breakpoint (price at which demand ceases), and P Conclusion: The MPT exhibits robust psychometric validity and may be useful to inform on cannabis regulatory science in Spain. Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [JM is a principal in Beam Diagnostics, Inc and has consulted to Clairvoyant Therapeutics, Inc.]. (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |